Summary
Pharmaceuticals in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Italian pharmaceuticals market had total revenues of $28.5m in 2018, representing a compound annual growth rate (CAGR) of 2.9% between 2014 and 2018.
- The performance of the market is forecast to decelerate, with an anticipated CAGR of 2.7% for the five-year period 2018-2023, which is expected to drive the market to a value of $32.5m by the end of 2023.
- Italian health market closely follows Germany, led by expertise in advances therapies and managed entry agreements for new drugs.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Italy
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Italy
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Italy pharmaceuticals market with five year forecasts
Reasons to buy
- What was the size of the Italy pharmaceuticals market by value in 2018?
- What will be the size of the Italy pharmaceuticals market in 2023?
- What factors are affecting the strength of competition in the Italy pharmaceuticals market?
- How has the market performed over the last five years?
- How large is Italy’s pharmaceuticals market in relation to its regional counterparts?
'
Table of Contents
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Chiesi Farmaceutici SpA
The Menarini Group
Pfizer Inc
Recordati S.p.A.
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
List of Tables
Table 1: Italy pharmaceuticals market value: $ billion, 2014-18
Table 2: Italy pharmaceuticals market geography segmentation: $ billion, 2018
Table 3: Italy pharmaceuticals market share: % share, by value, 2018
Table 4: Italy pharmaceuticals market value forecast: $ billion, 2018-23
Table 5: Chiesi Farmaceutici SpA: key facts
Table 6: The Menarini Group: key facts
Table 7: Pfizer Inc: key facts
Table 8: Pfizer Inc: key financials ($)
Table 9: Pfizer Inc: key financial ratios
Table 10: Recordati S.p.A.: key facts
Table 11: Recordati S.p.A.: key financials ($)
Table 12: Recordati S.p.A.: key financials (€)
Table 13: Recordati S.p.A.: key financial ratios
Table 14: Italy size of population (million), 2014-18
Table 15: Italy gdp (constant 2005 prices, $ billion), 2014-18
Table 16: Italy gdp (current prices, $ billion), 2014-18
Table 17: Italy inflation, 2014-18
Table 18: Italy consumer price index (absolute), 2014-18
Table 19: Italy exchange rate, 2014-18
List of Figures
Figure 1: Italy pharmaceuticals market value: $ billion, 2014-18
Figure 2: Italy pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 3: Italy pharmaceuticals market share: % share, by value, 2018
Figure 4: Italy pharmaceuticals market value forecast: $ billion, 2018-23
Figure 5: Forces driving competition in the pharmaceuticals market in Italy, 2018
Figure 6: Drivers of buyer power in the pharmaceuticals market in Italy, 2018
Figure 7: Drivers of supplier power in the pharmaceuticals market in Italy, 2018
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2018
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2018
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2018
Figure 11: Pfizer Inc: revenues & profitability
Figure 12: Pfizer Inc: assets & liabilities
Figure 13: Recordati S.p.A.: revenues & profitability
Figure 14: Recordati S.p.A.: assets & liabilities
